Some evidence also suggests that CD4+ Th1-like cells may contribute to the formation of granulomas, and anti-CTLA-4 therapy has been shown to increase the amounts of peripheral Th17 CD4+ cells that produce the proinflammatory cytokine IL-1720. Here, CTLA4 is linked to Granuloma.